TPT0801

N/A

Report date: 2024/09/13 11:18:15
NME

Base Information

Drug NameTPT0801
Drug Alias NameTPT0801TPT-0801
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCannabinoid CB1 receptor agonistsMonoglyceride lipase inhibitors
TargetsCannabinoid CB1 receptorMonoglyceride lipase
Therapy Area/IndicationsAttention Deficit Disorder with Hyperactivity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTetra Pharm Technologies ApS
China Registration ClassN/A

Develop Information

Active CompaniesTetra Pharm Technologies ApS
Inactive CompaniesN/A
Active IndicationsAttention Deficit Disorder with Hyperactivity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A